Bank7 Corp
For the period ended Sep 30, 2024. Filed Nov 5, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 5, 2024
BSVN$59.18+0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Shareholders’ Equity
Shareholders’ Equity
(Dollar amounts in thousands, except per share data)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Common Stock (Shares) | ||||
| Balance at beginning of period | 9,253,038 | 9,154,934 | 9,197,696 | 9,131,973 |
| Exercise of employee stock options | 87,819 | 13,124 | 106,820 | 26,986 |
| Shares issued for restricted stock units | 625 | 26,625 | 52,261 | 40,734 |
| Shares acquired and canceled | (215) | (9,708) | (15,510) | (14,718) |
| Balance at end of period | 9,341,267 | 9,184,975 | 9,341,267 | 9,184,975 |
| Common Stock (Amount) | ||||
| Balance at beginning of period | $93 | $92 | $92 | $91 |
| Shares issued for restricted stock units | - | - | 1 | 1 |
| Balance at end of period | $93 | $92 | $93 | $92 |
| Additional Paid-in Capital | ||||
| Balance at beginning of period | $98,570 | $96,498 | $97,417 | $95,263 |
| Shares purchased and retired for restricted stock units | (7) | (231) | (425) | (367) |
| Exercise of stock options | 1,576 | 236 | 1,906 | 480 |
| Stock-based compensation expense | 621 | 565 | 1,862 | 1,692 |
| Balance at end of period | $100,760 | $97,068 | $100,760 | $97,068 |
| Retained Earnings | ||||
| Balance at beginning of period | $97,891 | $73,901 | $78,962 | $58,049 |
| Net income | 11,777 | 7,853 | 34,589 | 27,206 |
| Cumulative effect of change in accounting principle, net of tax of $178 | - | - | - | (572) |
| Cash dividends declared ($0.24 and $0.21 per share for three months ended September 30, 2024 and 2023, respectively; $0.66 and $0.53 per share for the nine months ended September 30, 2024 and 2023, respectively) | (2,242) | (1,929) | (6,125) | (4,858) |
| Balance at end of period | $107,426 | $79,825 | $107,426 | $79,825 |
| Accumulated Other Comprehensive Loss | ||||
| Balance at beginning of period | $(5,748) | $(8,711) | $(6,145) | $(9,303) |
| Comprehensive income (loss) | 1,631 | (367) | 2,028 | 225 |
| Balance at end of period | $(4,117) | $(9,078) | $(4,117) | $(9,078) |
| Total Shareholders’ equity | $204,162 | $167,907 | $204,162 | $167,907 |
Unaudited Condensed Consolidated Statements of
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.